Peptides have emerged as promising therapeutic molecules due to their high specificity, low toxicity and excellent oral bioavailability. Over the past few decades, numerous peptide drugs have been approved for clinical use and many more are currently in clinical trials. Some of the key approved peptide drugs include insulin, glucagon-like peptide-1 receptor agonists, calcitonin, oxytocin,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian